<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM GENETIC VECTORS, INC.'S INTERIM CONSOLIDATED BALANCE SHEET AND STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS </LEGEND> <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-END> MAR-31-1997 <CASH> $4,255,674 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> $4,272,001 <PP&E> $55,768 <DEPRECIATION> 0 <TOTAL-ASSETS> $4,543,120 <CURRENT-LIABILITIES> $162,113 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> $2,340 <OTHER-SE> $4,378,667 <TOTAL-LIABILITY-AND-EQUITY> $4,543,120 <SALES> 0 <TOTAL-REVENUES> 0<F1> <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> $384,820<F1> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> ($366,270)<F1> <INCOME-TAX> 0 <INCOME-CONTINUING> ($366,270)<F1> <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> ($366,270)<F1> <EPS-PRIMARY> (0.16) <EPS-DILUTED> (0.16) <FN> <F1>For the quarter ended March 31, 1997. </FN>